Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. [electronic resource] by
- Matthews, G V
- Neuhaus, J
- Bhagani, S
- Mehta, S H
- Vlahakis, E
- Doroana, M
- Naggie, S
- Arenas-Pinto, A
- Peters, L
- Rockstroh, J K
Producer: 20151104
In:
HIV medicine vol. 16 Suppl 1
Availability: No items available.
|
|
10.
|
Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group. [electronic resource] by
- Gatell, J M
- González-Lahoz, J
- Clotet, B
- Antunes, F
- Kasparova, L
- Gil-Aguado, A
- Saballs, P
- Santamaria, J M
- Podzamczer, D
- Miro, J M
- Jou, A
- Verdejo, J
- Doroana, M
- Thomis, J
Producer: 19960813
In:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association vol. 12
Availability: No items available.
|
|
11.
|
Population mobility and the changing epidemics of HIV-2 in Portugal. [electronic resource] by
- Carvalho, A C
- Valadas, E
- França, L
- Carvalho, C
- Aleixo, M J
- Mendez, J
- Marques, R
- Sarmento, A
- Doroana, M
- Antunes, F
- Branco, T
- Aguas, M
- Sarmento E Castro, R
- Lazarus, J V
- Barros, H
Producer: 20120425
In:
HIV medicine vol. 13
Availability: No items available.
|